Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$3.61 - $7.01 $101,350 - $196,805
28,075 New
28,075 $121,000
Q3 2022

Nov 14, 2022

BUY
$4.68 - $8.34 $2,082 - $3,711
445 Added 1.6%
28,234 $150,000
Q2 2022

Aug 15, 2022

SELL
$4.87 - $9.41 $1,909 - $3,688
-392 Reduced 1.39%
27,789 $182,000
Q1 2022

May 16, 2022

BUY
$4.16 - $7.76 $31,495 - $58,750
7,571 Added 36.73%
28,181 $207,000
Q4 2021

Feb 14, 2022

BUY
$5.99 - $24.97 $123,453 - $514,631
20,610 New
20,610 $146,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $47.8M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.